Revelation Biosciences Stock (NASDAQ: REVB) stock price, news, charts, stock research, profile.
You can purchase shares of Revelation Biosciences (NASDAQ:REVB) through any online brokerage.
Other companies in Revelation Biosciences’s space includes: ZyVersa Therapeutics (NASDAQ:ZVSA), Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Entero Therapeutics (NASDAQ:ENTO) and Bone Biologics (NASDAQ:BBLG).
Revelation Biosciences has a consensus price target of $13.50.
The stock price for Revelation Biosciences (NASDAQ: REVB) is $0.322 last updated December 24, 2024 at 4:53 PM EST.
There are no upcoming dividends for Revelation Biosciences.
Revelation Biosciences’s Q4 earnings are confirmed for Friday, March 21, 2025.
There is no upcoming split for Revelation Biosciences.
Revelation Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.